2018
DOI: 10.1364/ome.8.003277
|View full text |Cite
|
Sign up to set email alerts
|

Lanthanide ions doped in vanadium oxide for sensitive optical glucose detection

Abstract: Blood glucose monitoring is essential to avoid the unwanted consequences of glucose level fluctuations. Optical monitors are of special interest because they can be non-invasive. Among optical glucose sensors, fluorescent upconversion nanoparticles (UCNPs) have the advantage of good photostability, low toxicity, and exceptional autofluorescence suppression. However, to sense glucose, UCNPs normally need surface functionalization, and this can be easily affected by other factors in biological systems, and may a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 49 publications
(64 reference statements)
0
2
0
Order By: Relevance
“…The LOD of these sensors are 0.33 mM, 10 mM and 0.5 mM, respectively. Besides ZnO, other nanomaterials were also successfully implemented in fluorescent glucose sensor such as graphene quantum dots in nanofibrous membrane [17], platinumporphyrin doped polymeric hybrid NPs [18], and lanthanide ions doped in vanadium oxide NPs [19]. The sensitivities of these sensors are 4.4% mM -1 , 1.9% mM -1 , and 0.7 % mM -1 , respectively.…”
Section: Introductionmentioning
confidence: 99%
“…The LOD of these sensors are 0.33 mM, 10 mM and 0.5 mM, respectively. Besides ZnO, other nanomaterials were also successfully implemented in fluorescent glucose sensor such as graphene quantum dots in nanofibrous membrane [17], platinumporphyrin doped polymeric hybrid NPs [18], and lanthanide ions doped in vanadium oxide NPs [19]. The sensitivities of these sensors are 4.4% mM -1 , 1.9% mM -1 , and 0.7 % mM -1 , respectively.…”
Section: Introductionmentioning
confidence: 99%
“…For example, a FreeStyle Libre, developed by Abbott Diabetes Care Inc. USA is available. However, the false-positive rate of hypoglycemia remains high [5]. Although it is minimally invasive, the use of needles does not solve the problems of pain and infection.…”
Section: Introductionmentioning
confidence: 99%